Using a panel of monoclonal antibodies and rabbit heteroantisera, we have studied the cell surface markers of peripheral blood (PB) Sezary cells from six patients with mycosis fungoides or Sezary syndrome, disease grouped within the spectrum of cutaneous T cell lymphomas (CTCL). Furthermore, we have studied two cell lines (Hut 78 and Hut 102) derived from malignant Sezary T cells from CTCL patients. The monoclonal antibody 3A1 defines a major human PB T cell subset (85% of PB T cells) while the antigen defined by the monoclonal antibody 4F2 is present on a subset (70%) of activated PB T cells and on circulating PB monocytes.
A B S T R A C T Using a panel of monoclonal antibodies and rabbit heteroantisera, we have studied the cell surface markers of peripheral blood (PB) Sezary cells from six patients with mycosis fungoides or Sezary syndrome, disease grouped within the spectrum of cutaneous T cell lymphomas (CTCL). Furthermore, we have studied two cell lines (Hut 78 and Hut 102) derived from malignant Sezary T cells from CTCL patients. The monoclonal antibody 3A1 defines a major human PB T cell subset (85% of PB T cells) while the antigen defined by the monoclonal antibody 4F2 is present on a subset (70%) of activated PB T cells and on circulating PB monocytes.
In contrast to normal subjects in whom 60-70% of circulating PB mononuclear cells were 3A1+ T cells, PB mononuclear cells from six CTCL patients studied had an average of only 10 .6±3.2% 3A1+ T cells. Whereas 85% of E-rosette positive cells from normal individuals were 3A1+, virtually all E-rosette positive T cells from the Sezary patients were 3A1-. Two patients with high numbers of circulating Sezary T cells had both aneuploid and diploid PB T cell populations present; after separation of PB T cells into 3A1+ and 3A1-cell suspensions, all 3A1-cells were found to be aneuploid. In contrast to normal resting PB T cells which were 4F2-, all PB Sezary cells were 4F2+, suggesting a state of activation. The 3A1 antigen was on a variety of acute lymphoblastic leukemia T cell lines (HSB-2, RPMI-8402, MOLT 4, CEM) but was absent on the Hut 78 and Hut 102 Sezary T cell lines.
Using rabbit anti-humani T and aniti-humiian Ia (p23, 30) antisera, we found that all malignant Sezary PB cells tested were killed by anti-T cell antiserum plus complement but not by anti-Ia plus comnplement. In contrast, Sezary cell lines Hut 78 and 102, were killed by both anti-T cell antiserum and aniti-Ia plus complement. Similar to 3A1-normal PB T cells, 3A1-Sezary PB T cells proliferated poorly to phytohemagglutinin and concanavalin A. However, 3A1-Sezary T cells were able to provide T cell help towards pokeweed mitogeninduced in vitro B cell immunoglobulin synthesis, an immunoregulatory function limited to 3A1+ T cells in normal subjects.
Thus, the 3A1 antigen is present on 85% of normal PB T cells, and on most T-acute lymphoblastic leukemia lines tested; in contrast the 3A1 antigen is not present on the majority of circulating malignant Sezary PB T cells nor on T cell lines derived from malignant Sezary T cells. The lack of expression of the 3A1 antigen may be associated with malignant transformation of T cells in CTCL and may be an important marker for tracing the clonal origin of the malignant Sezary T cell.
INTRODUCTION
Mycosis fungoides (MF)l and the Sezary syndrome (SS) are uncommon lymphoid malignancies that are part of the spectrum of cutaneous T cell lymphomas (CTCL) (1, 2) . Classic MF presents with a scaly eruption that progresses through a plaque stage leading to skin tumors (3) . MF patients are not overtly leukemic, although 25% of cases have circulating malignant Sezary cells (4) . SS is manifested by generalized exfoliative erythroderma and, as with MF, frequently is associated with circulating malignant T cells in the peripheral blood (PB) (3, 4) .
In most cases of MF and SS, the malignant Sezary cells have been shown to be T cells by reaction with antisera to human T lymphocyte antigens, lack of surface immunoglobulin (slg), and rosette formation with sheep erythrocytes (E) (5) .
In contrast to many leukemic lymphoblastic T cells which are thought to be derived from immature T cells (6) , the malignant T cells in SS and MF are thought to be derived from relatively mature T cells as determined by the absence of terminal deoxynucleotidyl transferase (7) , by the presence of in vitro helper T cell activity for B cell immunoglobulin synthesis (8) , and by the production of macrophage migration inhibitory factor (9) .
We have recently characterized several lymphocyte hybrid monoclonal antibodies that identify subsets of human PB resting and activated T cells (10) (11) (12) (13) . The present study reports the characterization of the Sezary T cell using three of these reagents. (18) . B lymphocytes were identified by the presence of surface membrane immunoglobin. Cells bearing Fc receptors for either IgG or IgM were determined as previously described (14) . Cells bearing human Ia determinants were determined by their ability to be lysed by anti-p23, 30 antiserum and C (19) . Cytotoxicity assays were carried out using a modification of the microcytotoxicity assay of Terasaki and McClelland (20) . Less than 20% of cells were killed in the presence of C alone.
METHODS
Lymphocyte hybrid monoclonal antibodies and flow cytofluorometry. Lymphocyte hybrid antibodies used included 3A1, 4F2, and 3F10 (11) . These three monoclonal antibodies were passed as ascites tumors in BALB/c mice; ascites fluid was harvested, isoelectrically focused or ammonium sulfate precipitated, and directly fluorsceinated for use in flow cytofluorometry (13) . The 3A1 monoclonal antibody recognizes a 40,000-mol wt cell surface T cell antigen which is on >90% of human thymocytes, 30-55% of spleen cells, and 85% of PB E-rosette positive T cells. 3A1+ T cells blast transform to phytohemagglutinin (PHA) and concanavalin A (Con A), induce in vitro B cell immunoglobulin synthesis, and also contain cells which can be induced by Con A to suppress immunoglobulin synthesis (13) . 3A1-T cells respond submaximally to PHA, not at all to Con A, and do not induce in vitro B cell immunoglobulin synthesis but do mediate antibody-dependent cellular cytotoxicity (13) . Antibody 4F2 binds to activated but not resting PB lymphocytes as well as to other types of rapidly dividing cells and to circulating PB monocytes (11, 12) . Antibody 3F10 precipitates the 44,000-mol wt nonpolymorphic HLA antigen and thus binds to all human cells that express HLAdeterminants (11) . Characteristics of the monoclonal antibodies used are summarized in Table I 
.). (23).
Solid-phase radioassay to measure cell-surface antibody binding. 5 x 105 cells were incubated in varying dilutions of3A1, 4F2, or 3F10 ascites fluid, washed three times in Dulbecco's phosphate-buffered saline with 0.1% gelatin and then incubated with affinity-purified 125I-labeled right anti-mouse IgG (20,000 cpm), and counted as previously described (10, 12) .
Fractionation of mononuclear cell suspensions. Purified T cells were isolated by rosetting mononuclear cells with sheep E followed by Hypaque-Ficoll centrifugation (14) .
3A1+ and 3A1-cell suspensions were obtained using 3AI-coated polystyrene plates (13 (22), and the DNA content of the cells measured in a Coulter TPS-1 cell sorter (Coulter Electronics) as previously described in detail (23) .
Lymiphocyte futnctional assay. In vitro lymphocyte cultures for the determination of blast transformation to mitogen stimutlationi, as measured by tritiated thymidine incorporation, or for pokeweed mitogein (PWM)-driven intracytoplasmic immunoglobin production were set up and assayed as previously described (18) .
RESULTS
Patients and cell lines studied. [16] ), on several ALL T cell lines, and on a variety of other cell lines (Table III) . As we have previously reported, the HSB-2 T cell (and all other ALL cell lines thus far tested) strongly bound 3A1 antibody in the 1251-rabbit anti-mouse IgG radioassay (10, 13) . All B cell lines tested thus far have been 3A1-. More imnportantly, as with the YT4E Sezary T cell (Table II) , we determined the cell-surface characteristics of PB Sezary cells from MF or SS patients. Normal subjects had a range of 65-80% 3A1+ cells in their PB mononuclear cells (10), while our six CTCL patients had an average of 10.6+3.2% 3A1+ PB mononuclear cells (Table IV) . Conversely, the CTCL patients had an abnormally high percentage of 3A1-PB mononuclear cells (89.3+3.2%) compared to normal subjects (range 20-35%). Thus, most of the patients had very high percentages and absolute counts of circulating malignant Sezary cells (Table II) and most of these cells were 3A1- (Table IV) . The flow cytofluorometry histogram of binding of directly fluoresceinated 3A1 antibody to normal unfractionated PB mononuclear cells (Fig. LA) and to normal purified T cells (Fig. 1B) demonstrates that 75% of normal PB (Fig. 2) . This helper T cell functional capability is similar to that which has been previously reported for Sezary T cells (8) . Similarly, as others have reported, Sezary T cells responded poorly to activation by PHA and Con A (26) (Fig. 3A and B) . Table VII summarizes the differences in cell-surface markers between normal PB T cells, Sezary PB cells, ALL T cell lines, and Sezary T cell lines.
DISCUSSION
The present study has used a panel of monoclonal antibodies and heteroantisera to study the cellsurface markers of the malignant Sezary T cell. While T Cell Antigens in Cutaneous T Cell Lymphoma IgM   morphology   110  86  100  0  0  100  0  30  95  155  95  100  0  0  100  1  10  97  163  60  100  0  0  100  21  0  98  167  65  100  0  0  100  ND" ND  90  185  99  100  0  0  100  7  8  97 * FcR, Fc receptors.
t Determined by microcytotoxicity assay using either rabbit anti-T cell antiserum (17, 18) (Table V) . However, Sezary PB T cells are positive for 4F2 antigen, a 120,000-mol wt antigen which is not found on resting lymphocytes but is found on Con A and mixed lymphocyte reaction-activated PB T cells, all dividing cell lines, and on PB monocytes (12) . The significance of this differential expression of the 4F2 antigen on normal and Sezary PB T cells is at present unknown. However, since the 4F2 antigen is present on normal activated T cells, it may reflect a certain relationship between malignant transformation and markers of cell activation.
It has previously been shown that anti-Sezary T cell heteroantisera reacted with different T cell-specific cell-surface antigens than did anti-monkey thymocyte antisera (27) or antisera raised against other leukemic cells or normal human thymocytes (28) . These data suggested that Sezary T cells express different cellsurface T cell antigens than do other types of normal or malignant T cells. Key to the further study of the clonal 
